Mark S Blumenkranz - Director, Avalanche Biotechnologies, Inc

As of June 15, 2015


Mark S Blumenkranz Net Worth

  • Net worth is estimated to be at least $10.47M
  • Owns at least 533,520 units of Avalanche Biotechnologies, Inc stock
  • Sold an estimated value of $1.1M recently at Avalanche Biotechnologies, Inc

Mark S Blumenkranz Trading

  • Largest sale of shares was 23,100 units , worth over $828.28K on June 11, 2015
  • In total has made about 3 transactions recently
  • Usually trades in June, with the busiest year in 2015
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Mark S Blumenkranz Mailing Address

  • Mailing address is C/o 1life Healthcare, Inc. One Embarcadero Center, Suite 1900 San Francisco CA 94111 CA

Avalanche Biotechnologies, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Total
Alfred F. Kelly, Jr. 2020 $1,550,076 - $17,026,616 $4,562,500 - - $ $26,364,928
Alfred F. Kelly, Jr. 2019 $1,400,059 - $14,246,423 $4,312,489 - - $36,800 $24,265,771
Alfred F. Kelly, Jr. 2018 $1,300,038 - $8,693,984 $3,500,008 - - $26,416 $19,493,946
Vasant M. Prabhu 2020 $1,100,050 - $8,039,757 $2,124,987 $1,209 $1,209 $23,850 $13,049,853
Vasant M. Prabhu 2019 $1,000,040 - $6,493,501 $1,625,005 $1,372 $1,372 $26,800 $11,586,718
Vasant M. Prabhu 2018 $1,000,038 - $5,848,193 $1,999,994 $1,215 $1,215 $16,500 $12,569,940
Ryan McInerney 2020 $1,100,050 - $9,439,901 $2,624,994 $3,227 $3,227 $27,100 $14,955,272
Ryan McInerney 2019 $900,047 - $7,133,141 $1,825,008 $3,600 $3,600 $30,621 $12,088,417
Ryan McInerney 2018 $900,035 - $6,777,537 $2,250,003 $3,351 $3,351 $21,500 $13,286,026
Rajat Taneja 2020 $1,100,050 - $8,939,651 $2,500,007 $1,743 $1,743 $20,850 $14,322,301
Rajat Taneja 2019 $900,047 - $6,977,836 $1,712,503 $1,969 $1,969 $22,215 $11,810,570
Rajat Taneja 2018 $900,035 - $6,803,356 $2,125,007 $1,769 $1,769 $17,750 $13,154,517
Paul Fabara 2020 $750,035 - $9,128,814 $3,381,227 - - $8,899,802 $23,059,878
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1403161/000119312520309539/d75661ddef14a.htm

Avalanche Biotechnologies, Inc Insider Trading

  • The most recent transaction was 500 units sold on June 17, 2015 by Mehdi Gasmi worth over $19.93K
  • In the last month, insiders at Avalanche Biotechnologies, Inc sold an estimated value of $4.83M and bought an estimated value of $20.05K
  • The most active traders are Mark S Blumenkranz, Director,  Paul Wachter, Director,  and Mehdi Gasmi, SVPPharmaceutical Development
  • Insider trading is most common in June, with the busiest year in 2015

Avalanche Biotechnologies, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1